MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, UTHR had -$140,100K decrease in cash & cash equivalents over the period. $1,040,700K in free cash flow.

Cash Flow Overview

Change in Cash
-$140,100K
Free Cash flow
$1,040,700K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Sales of available-for-sale debt...
    • Maturities of available-for-sale...
    • Net income
    • Others
Negative Cash Flow Breakdown
    • Purchases of available-for-sale ...
    • Payments to repurchase common st...
    • Purchases of property, plant, an...
    • Others

Cash Flow
2025-12-31
Net income
1,334,700
Depreciation and amortization
85,600
Share-based compensation expense
147,700
Impairments of property, plant, and equipment
21,700
Deferred income taxes
97,700
Other
19,700
Accounts receivable
70,900
Inventories
52,600
Accounts payable and accrued expenses
97,900
Other assets and liabilities
80,900
Net cash provided by operating activities
1,561,200
Purchases of property, plant, and equipment
520,500
Acquired lease intangible assets
5,500
Deposits
10,400
Purchases of available-for-sale debt securities
3,405,400
Maturities of available-for-sale debt securities
1,583,900
Sales of available-for-sale debt securities
1,861,600
Purchases of investments in privately-held companies
55,000
Acquisitions, net of cash acquired
0
Net cash (used in) provided by investing activities
-551,300
Payments to repurchase common stock
1,000,000
Proceeds from line of credit
200,000
Repayment of line of credit
500,000
Excise tax paid on net share repurchase
5,000
Payments of debt issuance costs
11,500
Proceeds from the exercise of stock options
173,900
Proceeds from the issuance of stock under espp
9,200
Rsus withheld for taxes
16,600
Net cash used in financing activities
-1,150,000
Net (decrease) increase in cash and cash equivalents
-140,100
Cash and cash equivalents, beginning of year
1,697,200
Cash and cash equivalents, end of year
1,557,100
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Net income$1,334,700K Share-based compensationexpense$147,700K Accounts payable andaccrued expenses$97,900K Deferred income taxes$97,700K Depreciation andamortization$85,600K Impairments of property,plant, and equipment$21,700K Net cash provided byoperating activities$1,561,200K Canceled cashflow$224,100K Net (decrease)increase in cash and cash...-$140,100K Canceled cashflow$1,561,200K Proceeds from line ofcredit$200,000K Proceeds from theexercise of stock options$173,900K Proceeds from theissuance of stock under...$9,200K Sales ofavailable-for-sale debt securities$1,861,600K Maturities ofavailable-for-sale debt securities$1,583,900K Other assets andliabilities$80,900K Accounts receivable$70,900K Inventories$52,600K Other$19,700K Net cash used infinancing activities-$1,150,000K Canceled cashflow$383,100K Net cash (used in)provided by investing...-$551,300K Canceled cashflow$3,445,500K Payments to repurchasecommon stock$1,000,000K Repayment of line of credit$500,000K Rsus withheld fortaxes$16,600K Payments of debt issuancecosts$11,500K Excise tax paid on netshare repurchase$5,000K Purchases ofavailable-for-sale debt securities$3,405,400K Purchases of property,plant, and equipment$520,500K Purchases of investmentsin privately-held...$55,000K Deposits$10,400K Acquired leaseintangible assets$5,500K

UNITED THERAPEUTICS Corp (UTHR)

UNITED THERAPEUTICS Corp (UTHR)